Weixinkang medicine - Innovation Achievement
The
company has obtained a total of 12 national invention patents, 16 new drug
certificates and helped the business partners acquire 59 approved drug
registration approvals under the company's technical support. After purchasing
Inner Mongolia Baiyi Pharmaceutical Co., Ltd. in 2012, the company has
independently researched and developed 28 projects of new products. The
potassium aspartate injection obtained the drug approval number in 2015. The
company's main production lines have all passed the new GMP certification,
namely the lines of the large-volume injection, small-volume injection for
terminal sterilization, small-volume injection for non-terminal sterilization,
and freeze-dried powder injection.